1. Home
  2. GOVX vs SGMA Comparison

GOVX vs SGMA Comparison

Compare GOVX & SGMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GOVX
  • SGMA
  • Stock Information
  • Founded
  • GOVX 2001
  • SGMA 1993
  • Country
  • GOVX United States
  • SGMA United States
  • Employees
  • GOVX N/A
  • SGMA N/A
  • Industry
  • GOVX Biotechnology: Pharmaceutical Preparations
  • SGMA Electrical Products
  • Sector
  • GOVX Health Care
  • SGMA Technology
  • Exchange
  • GOVX Nasdaq
  • SGMA Nasdaq
  • Market Cap
  • GOVX 7.6M
  • SGMA 6.2M
  • IPO Year
  • GOVX N/A
  • SGMA 1994
  • Fundamental
  • Price
  • GOVX $0.75
  • SGMA $3.01
  • Analyst Decision
  • GOVX Strong Buy
  • SGMA
  • Analyst Count
  • GOVX 4
  • SGMA 0
  • Target Price
  • GOVX $10.50
  • SGMA N/A
  • AVG Volume (30 Days)
  • GOVX 2.7M
  • SGMA 70.2K
  • Earning Date
  • GOVX 08-05-2025
  • SGMA 09-02-2025
  • Dividend Yield
  • GOVX N/A
  • SGMA N/A
  • EPS Growth
  • GOVX N/A
  • SGMA N/A
  • EPS
  • GOVX N/A
  • SGMA N/A
  • Revenue
  • GOVX $5,591,576.00
  • SGMA $311,706,094.00
  • Revenue This Year
  • GOVX N/A
  • SGMA N/A
  • Revenue Next Year
  • GOVX N/A
  • SGMA N/A
  • P/E Ratio
  • GOVX N/A
  • SGMA N/A
  • Revenue Growth
  • GOVX N/A
  • SGMA N/A
  • 52 Week Low
  • GOVX $0.43
  • SGMA $0.96
  • 52 Week High
  • GOVX $11.18
  • SGMA $6.47
  • Technical
  • Relative Strength Index (RSI)
  • GOVX 47.67
  • SGMA 72.22
  • Support Level
  • GOVX $0.60
  • SGMA $2.92
  • Resistance Level
  • GOVX $0.76
  • SGMA $3.00
  • Average True Range (ATR)
  • GOVX 0.08
  • SGMA 0.01
  • MACD
  • GOVX 0.02
  • SGMA -0.03
  • Stochastic Oscillator
  • GOVX 59.45
  • SGMA 100.00

About GOVX GeoVax Labs Inc.

Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.

About SGMA SigmaTron International Inc.

Sigmatron International Inc is an independent provider of electronic manufacturing services (EMS). It provides manufacturing and assembly services ranging from the assembly of individual components to the assembly and testing of box-build electronic products. The company manufactures products like printed circuit board assemblies, electro-mechanical subassemblies, and completely assembled (box-build) electronic products which are incorporated into finished products and sold in various industries, particularly industrial electronics, consumer electronics, and life sciences. In some instances, it manufactures and assembles the completed finished product for its customers. Geographically, the company derives maximum revenue from Mexico and the rest from the United States, China, and Vietnam.

Share on Social Networks: